Paul Mueller Company Reports Third Quarter Earnings for 2025
Financial Performance: Paul Mueller Company reported a net income of $3,225,000 for Q3 2025, down from $4,882,000 in Q3 2024, with total net sales for the nine months ending September 30, 2025, reaching $192,859,000, an increase from $178,111,000 in the previous year.
Backlog and Project Updates: The company's backlog as of September 30, 2025, is $250.4 million, reflecting a significant increase from $171.5 million in 2024, despite a $50.2 million reduction due to the cancellation of a large pharmaceutical project.
Dividend and Tender Offer: The board approved a tender offer at $485 per share, set to end on November 21, 2025, and declared a dividend of $0.30 per share payable on December 29, 2025, to shareholders of record on November 26, 2025.
Operational Challenges: The company faced production disruptions in Q3 due to challenges in large pharmaceutical projects, leading to adjustments in estimated costs that negatively impacted earnings, although overall profitability remained intact.
About the author






